Swissmedic Pharmacopoeia Unit (NPA)

Slides:



Advertisements
Similar presentations
18th amendment to constitution of pakistan
Advertisements

Current Issues & Challenges in the Development of Pharmacopoeial Monographs: European Pharmacopoeia Dr. Susanne Keitel European Directorate for the Quality.
The Federal Assembly – The Parliament of Switzerland A Production by the Parliamentary Services | 2014/2015.
Panel themes of the International Conference “Europe against Counterfeit Medicines” G.N. Gildeeva, Deputy head of the Department of Registration of Medicines.
Registration and Harmonisation in the Area of Medical Products in Switzerland Swiss Russian Health Forum Basel, 10./11. September 2012 Dr. Petra Dörr Head.
Federation of Chiropractic Licensing Boards 77th Annual Congress Orlando, Florida Accreditation 101 & Panel Discussion Saturday May 3, :00 – 10:00.
The Swiss Parliamentary Services – tasks, principles and challenges By Philippe Schwab, Secretary General of the Federal Assembly of Switzerland | March.
1 Dr S. Kopp WHO's normative functions in the field of pharmaceuticals WHO Expert Committee on Specifications for Pharmaceutical Preparations Secretary:
Federal Department of Home Affairs FDHA Federal Statistical Office FSO CES Seminar 2015: The Response by official statistics to the Sustainable Development.
1 The Practice of Granting SUPPLEMENTARY PROTECTION CERTIFICATES in the German Patent and Trademark Office (GPTO) Andrea Münzberg Chemical Patent Division.
“Empowering doctors to bring health to the nation” COMMENTS BY THE SOUTH AFRICAN MEDICAL ASSOCIATION (SAMA) on THE MEDICINES AND RELATED SUBSTANCES AMENDMENT.
1 The European Paediatric Initiative Agnès Saint Raymond, MD Scientific Advice and Orphan Drugs The European Medicines Evaluation Agency.
European Public Health Alliance Agnese Knabe Project coordinator European Public Health Alliance Civic Alliance – Latvia “Strengthening the networking.
2009 RWJF Synergy Workshop Institute of Medicine Washington DC June
1 Governance Structures in University Management Prof. Dr. Luc François - Maribor April 2009.
Major Activities Promoting Cleaner Production in Malta th Meeting of RAC/CP National Focal Points Barcelona, June 2003 Anton Pizzuto.
E C P E F EUROPEAN COMMISSION’S TECHNICAL ASSISTANCE INSTITUTIONAL BUILDING PARTNERSHIP PROGRAMME “Support of women and youth entrepreneurship in remote.
PRESIDENT ADMINISTRATIVE COUNCIL SCIENTIFIC COUNCIL COUNSELLOR ON MEDICAL ISSUES – EFFICACY AND SAFETY COUNSELLOR ON PHARMACEUTICAL ISSUES QUALITY ASSURANCE.
Jean-Marc Spieser, 23/09/09 ©2009 EDQM, Council of Europe, All rights reserved 1 Principles of Article 58 - possible support to 3rd countries for licensing.
The Research Council of Norway AdministrationCommunication Division for Science Division for Innovation Division for Strategic Priorities Director General.
FAO/WHO Codex Training Package Module 3.2 FAO/WHO CODEX TRAINING PACKAGE SECTION THREE – BASICS OF NATIONAL CODEX ACTIVITIES 3.2 How to develop national.
Recommended Textbooks in Veterinary Pharmacology.
ISPOR POLAND CHAPTER Polish Society of Pharmacoeconomics (PTFe )
EPHA Presentation EPHA, the EU and Health. EPHA Presentation European Public Health Alliance A network of more that 100 non governmental and not-for-profit.
Monograph Development Process for the European Pharmacopoeia: How to participate in the work programme of the European Pharmacopoeia Dr Claude Coune Head.
Principles of quality control of registered medicines, non- registered medicines and counterfeits of medical products Jean-Marc Spieser, Head of Department.
How to study Pharmacy in Germany Jan Schulte, Christian Weber German Pharmaceutical Students Association.
International Conference on Risk Assessment and Management: objectives and current status Valentin Nikonov, PhD (Economics), PMP IPMA, QMS Auditor, Coordinator.
Federal Department of Economic Affairs DEA / Federal Department of Home Affairs DHA Federal Food Chain Unit FFCU How to cope with “risk based” audit programs.
SynTech Research Spain SynTech Research Spain Regulatory Affairs.
Meeting for EU Generic Manufacturers and EU MA holders for generic medicines, Copenhagen, 26 November 2009 Generics approved by stringent regulatory authorities:
HOPE The European Hospital and Healthcare Federation.
European Public Health alliance Agnese Knabe Project coordinator European Public Health Alliance Civic Alliance – Latvia The Citizen in the centre in EU,
Organizational Structure Organizational Structure House of Delegates is comprised of 116 delegates Currently, there are 58 Chapters (one at each.
Status of Codex Alimentarius Program - Slovak Republic FAO/WHO –EURO Regional Training Seminar on Codex Alimentarius Ing. Zuzana Bírošová, CSc. Department.
© AL IPA/EDQM/IDMA Symposium 2007, All rights reserved The Ph. Eur. policy on impurities Dr Andrea Lodi Deputy Head, Laboratory Department, EDQM, Council.
COST European COoperation in Science and Technology COST European COoperation in Science and Technology Belspo, 14 March 2014 Benjamin MONNOYE, Attaché.
FORMATION AND FUNCTIONING OF INDIAN PHARMACOPOEIA COMMISSION (IPC) By Dr G N Singh Member-Secretary.
ALFREDO LOBO National Institute of Metrology, Standardization and Industrial Quality-Inmetro Director of Quality SECOND INTERNATIONAL FORUM ON MARKET SURVEILLANCE.
WHO Workshop on Assessment of Bioequivalence Data Addis Ababa, 31. August – 3. September 2010 Selection of comparators Compiled by Jan Welink WHO Workshop.
International conference Quality of Active Pharmaceutical Ingredients Hyderabad, September 2009 API Inspections: the EDQM experience – 7 September.
Conciliations and Codecision Secretariat The European Parliament in Brussels.
Dr R. Balocco Mattavelli, INN Programme Manager Informal Consultation on Medical devices, March 2011 INN Programme Dr Raffaella Balocco Mattavelli.
Prepared by: Imon Rahman Lecturer Department of Pharmacy BRAC University.
CLAUDIA PANAIT TAIEX Expert – European Commission Legal Adviser Ministry of Health, ROMANIA.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 6 – Company Law Bilateral screening:
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 1 – Free movement of goods Bilateral.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 20 – Enterprise and Industrial policy.
Slide 1 The contribution of a world-class regulatory environment to the future of the industry in Ireland Pat O’Mahony Chief Executive, Irish Medicines.
The Federal Assembly – The Parliament of Switzerland A Production by the Parliamentary Services | 2015/2016.
TRANSPOSITIONS OF THE EU LEGISLATION FOR HEALTH PROFESSIONS CHALLENGES AND ACHIEVEMENTS.
European Patients’ Academy on Therapeutic Innovation – The project is receiving support from the.
2.4 Public Policy How do the federal and provincial governments make public policy?
Who Are We? A Forum of Stakeholders Who Come together to Develop Science-based Solutions.
Karen Harrowing – Senior Associate
Community Pharmacy: Sharing Our Vision
EU-Russia Cooperation in the Areas of Science, Research and Innovation
“Responsible for Information and Publicity”
Swiss Fight Against Malnutrition – Impact of an Official Curriculum
Swiss Fight Against Malnutrition – Impact of an Official Curriculum
IEC and Information Technology
Food safety and food law enforcement in Switzerland
The Swiss Parties and Europe – a look at the parties on the ground and an explanation for the success of the Swiss People’s Party Conference on Alpine.
Setting up an ERIC 11 May 2012 Richard Derksen
Health and Consumer Protection Sector: Biotechnology
The Swiss Parliamentary Services – tasks, principles and challenges
Executive Office of the President (EOP)
Participation of the private and academic sectors in ITU activities
The European Pharmacopoeia and Pharmeuropa
Abnormal toxicity test (ATT) -
Presentation transcript:

Swissmedic Pharmacopoeia Unit (NPA) The Pharmacopoeia Network in Switzerland CH-Delegation to the Ph.Eur. Commission (6) Certification Ph. Eur. (7) Ph. Eur. Experts (CH) (75) · Groups of Experts (26) · Working Parties (49) Editorial Conference Ph. Eur. (2) Translation of the Ph.Eur. into German (2) Swissmedic Pharmacopoeia Unit (NPA) Confederation DFA DHA Swissmedic Expert Committees (FA) and (AGr) (72) FDF, SFOBL Licensing · Biological Products (15) Marketing Authorisation · Chemistry (14) OMCL Laboratories · Comlementary Medicinal Products (9) Market Surveillance · Galenicals (11) · Phytochemistry (13) · Working Group (10) Swiss Pharmacopoeia Commission (SPK) (13) Abbreviations (6) Numbers in parentheses: Number of Swiss experts active in this panel/ committee Professional circles involved in these panels: • Industry • Authorities • Academia • Pharmacists: - Community-, Hospital- and Army - Cantonal pharmacists Associations: - Swiss Pharmacists‘ Association - Swiss Society of Public Health and Hospital Pharmacists Certification Ph.Eur. Certifies that the Ph.Eur. controls a pharmaceutical substance of a certain manufacturer adequately, which facilitates the elaboration of licensing-documentation CH-Delegation Swiss Delegation to the European Pharmacopoeia Commission; one of 37 national delegations DFA Federal Department of Foreign Affairs; approves the budget and carries political responsibility DHA Federal Department of Home Affairs, appoints the Swiss delegation FA Expert Committees; elaborate scientific comments on the Ph.Eur. and contributions to the Swiss Pharmacopoeia FDF, SFOBL Swiss Federal Department of Finance, Swiss Federal Office of Buildings and Logistics; distribute the Pharmacopoeia NPA National Pharmacopoeia Authority, Pharmacopoeia Unit, Swissmedic OMCL Official Medicines Control Laboratories, Swissmedic Ph.Eur. European Pharmacopoeia; published by the Council of Europe Ph.Eur. Experts Swiss experts who participate in expert groups of the European Pharmacopoeia SPK Swiss Pharmacopoeia Commission; advises Swissmedic in the elaboration of the Pharmacopoeia 20.11.2009 / stu